Search

Larry D Worrell Jr

Examiner (ID: 1439, Phone: (571)272-4997 , Office: P/3765 )

Most Active Art Unit
3765
Art Unit(s)
3765, 3732, 2407, 3741, 3408
Total Applications
3310
Issued Applications
2742
Pending Applications
135
Abandoned Applications
431

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13622161 [patent_doc_number] => 20180362632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => ANTI-GM-CSF ANTIBODIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/100063 [patent_app_country] => US [patent_app_date] => 2018-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19894 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100063 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/100063
Anti-GM-CSF antibodies and uses thereof Aug 8, 2018 Issued
Array ( [id] => 14102307 [patent_doc_number] => 20190092829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => INHIBITION OF IL-17 PRODUCTION [patent_app_type] => utility [patent_app_number] => 15/957879 [patent_app_country] => US [patent_app_date] => 2018-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13865 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957879 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/957879
INHIBITION OF IL-17 PRODUCTION Apr 18, 2018 Abandoned
Array ( [id] => 13476565 [patent_doc_number] => 20180289825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => Single Chain Fc Fusion Proteins [patent_app_type] => utility [patent_app_number] => 15/949596 [patent_app_country] => US [patent_app_date] => 2018-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18104 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15949596 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/949596
Single chain Fc fusion proteins Apr 9, 2018 Issued
Array ( [id] => 16756619 [patent_doc_number] => 10975157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Anti-OX40 antibodies and diagnostic uses thereof [patent_app_type] => utility [patent_app_number] => 15/921254 [patent_app_country] => US [patent_app_date] => 2018-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14841 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15921254 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/921254
Anti-OX40 antibodies and diagnostic uses thereof Mar 13, 2018 Issued
Array ( [id] => 13386443 [patent_doc_number] => 20180244763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => ANTI-TGF-BETA ANTIBODIES AND THEIR USE [patent_app_type] => utility [patent_app_number] => 15/875532 [patent_app_country] => US [patent_app_date] => 2018-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875532 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/875532
Anti-TGF-b antibodies and their use Jan 18, 2018 Issued
Array ( [id] => 12794947 [patent_doc_number] => 20180156818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE [patent_app_type] => utility [patent_app_number] => 15/858661 [patent_app_country] => US [patent_app_date] => 2017-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27722 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15858661 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/858661
METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE Dec 28, 2017 Abandoned
Array ( [id] => 13331245 [patent_doc_number] => 20180217160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => IL1RL-1 as a Cardiovascular Disease Marker and Therapeutic Target [patent_app_type] => utility [patent_app_number] => 15/849135 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32030 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849135 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/849135
IL1RL-1 as a cardiovascular disease marker and therapeutic target Dec 19, 2017 Issued
Array ( [id] => 12794962 [patent_doc_number] => 20180156823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => METHODS OF DETERMINING RISK OF CARDIAC ARRHYTHMIA [patent_app_type] => utility [patent_app_number] => 15/830886 [patent_app_country] => US [patent_app_date] => 2017-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830886 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/830886
METHODS OF DETERMINING RISK OF CARDIAC ARRHYTHMIA Dec 3, 2017 Abandoned
Array ( [id] => 12157356 [patent_doc_number] => 20180028621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'METHODS OF INDUCING INDOLAMINE 2,3 - DIOXYGENASE (IDO)' [patent_app_type] => utility [patent_app_number] => 15/785075 [patent_app_country] => US [patent_app_date] => 2017-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/785075
METHODS OF INDUCING INDOLAMINE 2,3 - DIOXYGENASE (IDO) Oct 15, 2017 Abandoned
Array ( [id] => 12178711 [patent_doc_number] => 20180037647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-08 [patent_title] => 'Cachexia Treatment' [patent_app_type] => utility [patent_app_number] => 15/730218 [patent_app_country] => US [patent_app_date] => 2017-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5742 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15730218 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/730218
Cachexia treatment Oct 10, 2017 Issued
Array ( [id] => 13399921 [patent_doc_number] => 20180251503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => MULTIMERIZATION TECHNOLOGIES [patent_app_type] => utility [patent_app_number] => 15/715499 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15715499 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/715499
MULTIMERIZATION TECHNOLOGIES Sep 25, 2017 Abandoned
Array ( [id] => 15882871 [patent_doc_number] => 10647767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-12 [patent_title] => Anti-GM-CSF antibodies and uses thereof [patent_app_type] => utility [patent_app_number] => 15/744734 [patent_app_country] => US [patent_app_date] => 2017-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 12 [patent_no_of_words] => 19981 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744734 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/744734
Anti-GM-CSF antibodies and uses thereof Sep 17, 2017 Issued
Array ( [id] => 15225099 [patent_doc_number] => 10500254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen [patent_app_type] => utility [patent_app_number] => 15/695587 [patent_app_country] => US [patent_app_date] => 2017-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6199 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695587 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/695587
Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen Sep 4, 2017 Issued
Array ( [id] => 16215138 [patent_doc_number] => 10730936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-04 [patent_title] => Engineered anti-TGF-b antibodies and antigen-binding fragments [patent_app_type] => utility [patent_app_number] => 15/670631 [patent_app_country] => US [patent_app_date] => 2017-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14224 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15670631 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/670631
Engineered anti-TGF-b antibodies and antigen-binding fragments Aug 6, 2017 Issued
Array ( [id] => 11993987 [patent_doc_number] => 20170298142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'ANTIBODIES TO TIP-1 AND GRP78' [patent_app_type] => utility [patent_app_number] => 15/628209 [patent_app_country] => US [patent_app_date] => 2017-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 17533 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15628209 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/628209
Antibodies to GRP78 Jun 19, 2017 Issued
Array ( [id] => 12657013 [patent_doc_number] => 20180110837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION [patent_app_type] => utility [patent_app_number] => 15/621062 [patent_app_country] => US [patent_app_date] => 2017-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30643 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15621062 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/621062
METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION Jun 12, 2017 Abandoned
Array ( [id] => 12118850 [patent_doc_number] => 20180002436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'TARGETED TGFß INHIBITION' [patent_app_type] => utility [patent_app_number] => 15/617876 [patent_app_country] => US [patent_app_date] => 2017-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22905 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617876 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/617876
TARGETED TGFß INHIBITION Jun 7, 2017 Abandoned
Array ( [id] => 11971201 [patent_doc_number] => 20170275354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'ANTIBODIES TO M-CSF' [patent_app_type] => utility [patent_app_number] => 15/614237 [patent_app_country] => US [patent_app_date] => 2017-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 39529 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15614237 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/614237
Antibodies to M-CSF Jun 4, 2017 Issued
Array ( [id] => 12150101 [patent_doc_number] => 20180021365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'ENHANCED CANCER TREATMENT AND MONITORING USING RECOMBINANT VECTORS' [patent_app_type] => utility [patent_app_number] => 15/611722 [patent_app_country] => US [patent_app_date] => 2017-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37729 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611722 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/611722
ENHANCED CANCER TREATMENT AND MONITORING USING RECOMBINANT VECTORS May 31, 2017 Abandoned
Array ( [id] => 11963633 [patent_doc_number] => 20170267784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS' [patent_app_type] => utility [patent_app_number] => 15/608255 [patent_app_country] => US [patent_app_date] => 2017-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 37940 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15608255 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/608255
SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS May 29, 2017 Abandoned
Menu